abstract |
The invention provides compounds of formula (I) wherein R, R, R, R, R, R, L, X and Y are as defined in the specification; together with processes and intermediates for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of human neutrophil elastase. |